Genetically proxied inhibition of Phosphodiesterase-5 and cancer risks: A drug-target Mendelian randomization analysis
Sci Rep. 2025 Jul 23;15(1):26716. doi: 10.1038/s41598-025-12788-9.
Article
Jul 23, 2025